Realbotix increases private placement to $7-million

Mr. Andrew Kiguel reports REALBOTIX ANNOUNCES UPSIZE OF BROKERED LIFE OFFERING OF UP TO C$7,000,000 As a result of strong investor demand, Realbotix Corp. has increased the size of its previously announced brokered private placement pursuant to Part 5A of National Instrument 45-106 (Prospectus Exemptions) as amended and supplemented by Coordinated Blanket Order 45-935 (Exemptions from Certain Conditions of the Listed Issuer Financing Exemption). The private placement will consist of the issuance of up to 14 million units of the company at a price of 50 cents per unit for aggregate gross proceeds of up to $7-million (or approximately $5-million (U.S.)). The units are expected to be subscribed for in full by a single institutional investor. A.G.P. Canada Investments ULC is acting as the sole bookrunner and agent for the offering. Each unit to be issued under the life issuer financing exemption will consist of one common share in the capital of the company and one common share purchase warrant. Each warrant will entitle the holder thereof to acquire one common share at an exercise price of 75 cents for a period of five years after the closing date (as defined below). The company intends to use the net proceeds from the offering to advance the engineering, design and commercialization of its artificial-intelligence-powered humanoid robots and for working capital and general corporate purposes. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, the units issuable under the offering will be offered for sale to purchasers resident in each of the provinces of Canada, other than Quebec, pursuant to the listed issuer financing exemption. The units may also be issued in the United States pursuant to exemptions from the registration requirements in Regulation D of the U.S. Securities Act of 1933, as amended, and offshore jurisdictions. An amended and restated offering document dated Oct. 22, 2025, related to the offering can be accessed under the company's profile on SEDAR+ and on the company's website. Prospective investors should read this offering document before making an investment decision. The offering is expected to close on or about Oct. 24, 2025, or such other date as may be determined by the company and the agent, and is subject to the company receiving all necessary regulatory approvals, including the conditional acceptance of the TSX Venture Exchange. As the offering is being completed pursuant to the listed issuer financing exemption, the securities issued pursuant to the offering, including the common shares and warrants underlying the units and, upon exercise of the warrants, the warrant shares, will not be subject to a hold period under applicable Canadian securities laws. About Realbotix Corp. Realbotix designs and manufactures artificial-intelligence-powered intelligent humanoid robots for entertainment, customer service and companionship. Manufactured in the United States, Realbotix's patented AI and robotics technologies enable lifelike expressions, motion, vision and social engagement, positioning it as a category leader in the rapidly evolving field of human-centric robotics. We seek Safe Harbor.